Comparison of shockwave frequencies of 30 and 60 shocks per minute for kidney stones: a prospective randomized study
Scand J Urol · 2016 · Vol. 50 · Issue 6 · 477-482
Academy Summary
Comparison of shockwave frequencies of 30 and 60 shocks per minute for kidney stones: a prospective randomized study examined a clinically important component of shock wave lithotripsy, with particular relevance to SWL Treatment Optimisation.
The investigators used a Prospective Randomized Controlled Trial in adults with kidney stones. This design strengthens comparison between the treatment strategies studied, although the conclusions still remain tied to the lithotripter, protocol and eligibility criteria used.
A randomized renal-stone study compared 30 with 60 shocks/min, examining whether an ultraslow rate provides additional fragmentation benefit at the cost of longer treatment time.
Shock-wave rate changes the effectiveness of each shock, not only the duration of the procedure.
The rate literature is central to modern SWL optimisation because it demonstrates that treatment speed and treatment efficiency are not synonymous. Slower delivery can allow cavitation bubbles to dissipate and may improve fragmentation efficiency, although the optimal rate must balance efficacy and treatment time.
Published in 2016, the study should still be interpreted according to its specific lithotripter, patient selection and outcome definitions rather than assumed to represent every modern SWL system.
For the Lithotripsy Academy database, the paper is most useful when interpreted as part of the complete treatment pathway rather than as an isolated numerical rule. Patient selection determines the opportunity for success, while targeting, coupling, shock-wave rate, energy strategy and operator technique determine how effectively that opportunity is converted into fragmentation and clearance.
Comments & Discussion0 comments
Discuss the publication's evidence, limitations and practical relevance. Please do not include identifiable patient information or individual medical advice.
No comments yet. Start the discussion.
Please log in to join the discussion.
